New Haven Pharmaceuticals gets $1.5M investment; Drug-eluting stents safe and effective;

> Second-generation drug-eluting stents are safe and effective in the treatment of left main coronary artery lesions, according to results at the 24th Annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Press release

> Oral controlled release company New Haven Pharmaceuticals has received a $1.5M investment from Connecticut Innovations as part of a $6.6M Series A funding round. Press release

> Drug-eluting balloons are as effective as drug-eluting stents in opening up restenosed arteries. Article

> The U.S. FDA has accepted Ferring Pharmaceuticals' filing of an NDA for its controlled release misoprostol vaginal insert, used in childbirth. Press release

And Finally... Drug-coated stents may have benefits over bare metal stents in patients over 80. Article